Comparison

Opaganib European Partner

Item no. TMO-T6750-2mg
Manufacturer TargetMol
CASRN 915385-81-8
Amount 2 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,9971
Citations 1. Britten CD., A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2017 Apr 18. pii: clincanres.2363.2016.
Smiles Clc1ccc(cc1)C12CC3CC(CC(C3)(C1)C(=O)NCc1ccncc1)C2
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias ABC294640
Shipping Condition Cool pack
Available
Manufacturer - Targets
S1P Receptor
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
380.91
Description
Opaganib (ABC294640) is an orally active and specific sphingosine kinase-2 (SphK2) inhibitor (IC50: 60 μM).
Pathways
GPCR/G Protein

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close